FDA Inspection 1115168 — David Gallinson, DO

David Gallinson, DO — FEI 3015978892

The FDA completed an inspection of David Gallinson, DO on Dec 18, 2019 in Florham Park, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Dec 18, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Florham Park, NJ (United States)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.